Evaluating the Utility and Constraints of the Competitive Counter Flow (CCF) Assay in OATP1B1 Substrate Profiling.
Saved in:
| Title: | Evaluating the Utility and Constraints of the Competitive Counter Flow (CCF) Assay in OATP1B1 Substrate Profiling. |
|---|---|
| Authors: | Mathialagan S; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA., West MA; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA., Yamaguchi E; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA., Moulton HM; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA., Kapinos B; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA., Paryad Zanjani S; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA., Tess DA; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Cambridge, Massachusetts , USA., Kimoto E; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA., Varma MVS; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA., Yee SW; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA. sookwah.yee@pfizer.com. |
| Source: | The AAPS journal [AAPS J] 2026 May 06; Vol. 28 (3). Date of Electronic Publication: 2026 May 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42091780 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluating the Utility and Constraints of the Competitive Counter Flow (CCF) Assay in OATP1B1 Substrate Profiling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mathialagan+S%22">Mathialagan S</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22West+MA%22">West MA</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Yamaguchi+E%22">Yamaguchi E</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Moulton+HM%22">Moulton HM</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Kapinos+B%22">Kapinos B</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Paryad+Zanjani+S%22">Paryad Zanjani S</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Tess+DA%22">Tess DA</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Cambridge, Massachusetts , USA.<br /><searchLink fieldCode="AU" term="%22Kimoto+E%22">Kimoto E</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Varma+MVS%22">Varma MVS</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Yee+SW%22">Yee SW</searchLink>; Pharmacokinetics, Dynamics and Metabolism, ADME Sciences, Pfizer Inc, Groton, Connecticut, USA. sookwah.yee@pfizer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101223209%22">The AAPS journal</searchLink> [AAPS J] 2026 May 06; Vol. 28 (3). <i>Date of Electronic Publication: </i>2026 May 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+of+Pharmaceutical+Scientists%22">American Association of Pharmaceutical Scientists </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101223209 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1550-7416 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215507416%22">15507416 </searchLink><i>NLM ISO Abbreviation: </i>AAPS J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42091780 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1208/s12248-026-01251-w Languages: – Code: eng Text: English Titles: – TitleFull: Evaluating the Utility and Constraints of the Competitive Counter Flow (CCF) Assay in OATP1B1 Substrate Profiling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mathialagan S – PersonEntity: Name: NameFull: West MA – PersonEntity: Name: NameFull: Yamaguchi E – PersonEntity: Name: NameFull: Moulton HM – PersonEntity: Name: NameFull: Kapinos B – PersonEntity: Name: NameFull: Paryad Zanjani S – PersonEntity: Name: NameFull: Tess DA – PersonEntity: Name: NameFull: Kimoto E – PersonEntity: Name: NameFull: Varma MVS – PersonEntity: Name: NameFull: Yee SW IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 05 Text: 2026 May 06 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1550-7416 Numbering: – Type: volume Value: 28 – Type: issue Value: 3 Titles: – TitleFull: The AAPS journal Type: main |
| ResultId | 1 |